| Congestive heart failure (CHF) |
| Q10 | Ubiquinone | Modest, at best | Antioxidant; positive ionotrope | Liquid, capsules | 100 to 200 mg per day | None recorded | None recorded |
| Hawthorn | Crataegus species, haw, may, whitethorn | Incomplete, but highly promising data; approved for use in Germany and Asia for mild cases of CHF | Vasodilatory effects; increased coronary flow; decreased peripheral resistance; ACE–inhibitor-like effect | Dry extracts or liquid | Average daily dosage: 5 g or 160 to 900 mg extract for a minimum a minimum of 6 weeks | None recorded | May interfere with digoxin or digoxin monitoring |
| Hypercholesterolemia |
| Garlic | Allium sativum, poor man's treacle | Not efficacious | None | Fresh, oil, aqueous, fermented or dried | | Large quantities can cause stomach stomach complaints | None recorded |
| Soy | Glycine soja | Proved efficacy; will decrease total cholesterol 5 to 9%, LDL 13% | Estrogen-like properties; alters hepatic cholesterol metabolism | Extract | Average daily dosage: 25 g soy protein | Possible occasional stomach pain loose stool and diarrhea | None recorded |
| Cholestin | Went yeast, Monascus purpureus, fermented on rice | As efficacious as commercial Statins | HMG CoA reductase inhibitor | Capsules | 1,200 mg twice daily | Possible liver enzyme elevation and myositis; none, however, recorded | Same as commercially available statins |
| Gugulipid/guggal gum | Commiphora molmol, Arabian myrrh, Somalian myrrh | Preliminary data promising; needs larger controlled studies; widely used in India | Increased hepatic LDL binding sites* | Extract powdered resin; concentrated tablets | 75 mg per day | None recorded† | None recorded |